Breaking News Instant updates and real-time market news.

AEIS

Advanced Energy

$48.76

0.48 (0.99%)

, BHE

Benchmark Electronics

$26.44

0.195 (0.74%)

08:25
08/14/19
08/14
08:25
08/14/19
08:25

Needham to hold a conference

8th Annual Industrial Technologies 1:1 Conference will be held in New York on August 14.

AEIS

Advanced Energy

$48.76

0.48 (0.99%)

BHE

Benchmark Electronics

$26.44

0.195 (0.74%)

COHR

Coherent

$143.33

7.59 (5.59%)

CUB

Cubic

$68.40

-0.735 (-1.06%)

FARO

Faro Technologies

$49.70

0.64 (1.30%)

FLIR

Flir Systems

$47.31

0.04 (0.08%)

IPGP

IPG Photonics

$121.87

3.18 (2.68%)

IRBT

iRobot

$66.19

0.63 (0.96%)

KRNT

Kornit Digital

$27.88

0.31 (1.12%)

LASR

nLight

$14.85

0.38 (2.63%)

MKSI

MKS Instruments

$75.90

1.93 (2.61%)

PI

Impinj

$38.00

1.88 (5.20%)

TTMI

TTM Technologies

$10.63

0.09 (0.85%)

EPAY

Bottomline Technologies

$42.68

1.07 (2.57%)

EVER

EverQuote

$21.28

1.4 (7.04%)

WNS

WNS Holdings

$62.70

0.36 (0.58%)

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 15

    Aug

  • 21

    Aug

  • 03

    Sep

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

  • 10

    Sep

  • 12

    Sep

  • 17

    Sep

  • 19

    Sep

  • 26

    Sep

  • 02

    Oct

  • 03

    Oct

  • 23

    Oct

  • 13

    Nov

AEIS Advanced Energy
$48.76

0.48 (0.99%)

05/15/19
SUSQ
05/15/19
UPGRADE
Target $82
SUSQ
Positive
Susquehanna upgrades Advanced Energy to Positive on Applied Materials gains
As previously reported, Susquehanna analyst Mehdi Hosseini upgraded Advanced Energy (AEIS) to Positive from Neutral, stating that he believes the company is poised to benefit from market share gains made by its largest customer, Applied Materials (AMAT). As Hosseini told investors in his separate upgrade of Applied Materials to Positive, his recent checks suggest that the company has won "major" memory design wins that should help it regain lost share. He thinks Applied gaining memory share is "particularly positive" for Advanced's semi system business unit, the analyst stated. Hosseini raised his price target on Advanced Energy shares to $82 from $45.
05/15/19
05/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Westlake Chemical (WLK) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the stock's 49% decline over the past year has created an opportunity to gain exposure to two commodity cycles that are bottoming, ethylene and chloralkali. 2. Zillow (ZG, Z) upgraded to Buy from Neutral at Guggenheim with analyst Jake Fuller saying its recent results prove that demand for Offers "is real" and he expects the company's Offers business to surpass its ad business by Q4 and generate greater than $1B of revenue in its first full year. 3. Chevron (CVX) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Neil Mehta saying Chevron's cash flow profile has positively inflected with the production contribution and capital spending roll-off from the startup of both the Gorgon and Wheatstone LNG projects. 4. Hess Corp. (HES) upgraded to Equalweight from Underweight at Capital One with analyst Phillips Johnston saying he reviewed his model post Q1 earnings and "massively" overhauled his Guyana production estimates. 5. Applied Materials (AMAT) and Advanced Energy (AEIS) upgraded to Positive from Neutral at Susquehanna. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/08/19
DADA
07/08/19
DOWNGRADE
DADA
Neutral
Advanced Energy downgraded to Neutral from Buy at DA Davidson
07/08/19
07/08/19
DOWNGRADE

Neutral
Semiconductor Capital Equipment group cut to Neutral at DA Davidson on valuation
As previously reported, DA Davidson analyst Thomas Diffely cut his ratings on Lam Research (LRCX), Kulicke and Soffa (KLIC), Ichor Holdings (ICHR), Applied Materials (AMAT), and Advanced Energy Services (AEIS) to Neutral from Buy as part of his broader research note downgrading the Semiconductor Capital Equipment group following its "significant" year-to-date appreciation. The analyst cites the delayed recovery in memory along with the "cycle uncertainty" in assigning more "conservative" valuation multiples to these stocks and believes that their risk-reward profiles look "fairly balanced" at current levels. Diffely also lowers his price target on Lam Research to $200 from $225, Kulicke and Soffa to $26 from $30, Ichor Holdings to $25 from $32, Applied Materials to $45 from $55, and Advanced Energy Services to $55 from $60.
BHE Benchmark Electronics
$26.44

0.195 (0.74%)

04/30/19
NEED
04/30/19
INITIATION
NEED
Hold
Benchmark Electronics initiated with a Hold at Needham
Needham analyst James Ricchiuti resumed coverage of Benchmark Electronics with a Hold rating after its in-line Q1 results last week that showed lower gross margins due to the decline in the more-profitable semi-cap business. The analyst cites the delayed recovery for OEMs in that segment this year as one of the headwinds faced by the company and also warns that Benchmark Electronics may see nearly no growth in its overall business in 2020. Ricchiuti notes however that he may turn more constructive on the shares in the coming months if visibility on its performance improves or if there is a pullback in the stock price.
01/18/19
SIDC
01/18/19
INITIATION
Target $34
SIDC
Buy
Benchmark Electronics initiated with a Buy at Sidoti
Sidoti initiated Benchmark Electronics with a Buy rating and $34 price target.
COHR Coherent
$143.33

7.59 (5.59%)

01/30/19
01/30/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Allergan (AGN) downgraded to Sector Perform from Outperform at RBC Capital and to Equal Weight from Overweight at Morgan Stanley. 2. Whirlpool (WHR) downgraded to Underperform from Sector Perform at RBC Capital and to Market Perform from Outperform at Raymond James. 3. Olin (OLN) and Westlake Chemical (WLK) were downgraded to Reduce from Neutral at Nomura Instinet. 4. Coherent (COHR) downgraded to Hold from Buy at Needham with analyst James Ricchiuti citing the compnay's in-line Q1 results and "much weaker" than expected Q2 guidance along with withdrawn outlook FY19. 5. Carnival (CCL) downgraded to Hold from Buy at Standpoint Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/27/19
NRCS
02/27/19
NO CHANGE
NRCS
January Laser Industry survey shows continued mixed outlook, says Northcoast
Northcoast analyst Tom Hayes says his January Laser Industry survey showed some deterioration on a sequential basis as domestic respondents were less optimistic for Q1 and the international market continues to be choppy with limited visibility. While most respondents in his survey continue to expect growth in Q1 and 2019, the analyst notes that a combination of geopolitical headwinds, palpably weaker outlook and lack of clarity in the space gives him pause. Consequently, he reiterates a Neutral rating on nLight (LASR), IPG Photonics (IPGP) and Coherent (COHR).
04/29/19
SUSQ
04/29/19
DOWNGRADE
SUSQ
Neutral
Coherent downgraded to Neutral from Positive at Susquehanna
05/16/19
BNCH
05/16/19
NO CHANGE
BNCH
II-VI, Lumentum may be hurt by Huawei news, says Benchmark
After the U.S. Commerce Department added Huawei Technologies and 70 affiliates to its "Entity List," which bans the Chinese company from acquiring components and technology from U.S. companies without government approval, Benchmark analyst Mark Miller noted that prior restrictions negatively impacted II-VI (IIVI), which counts Huawei among its customers. He also believes Lumentum (LITE) may be unfavorably impacted as Huawei represents about 15% of its revenue. Huawei has contributed about 13% of Micron's (MU) sales in the last two quarters and shares of Western Digital (WDC) often trade in a similar manner to Micron, added Miller. Others that he sees potentially being negatively impacted by the Huawei news include IPG Photonics (IPGP), Coherent (COHR), nLight (LASR) and Veeco (VECO).
CUB Cubic
$68.40

-0.735 (-1.06%)

02/15/19
02/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cubic (CUB) initiated with a Buy at Citi. 2. Del Frisco's (DFRG) initiated with a Neutral at JPMorgan. 3. Lindblad Expeditions (LIND) initiated with a Buy at Stifel. 4. CareDx (CDNA) initiated with a Buy at Jefferies. 5. AcelRx (ACRX) initiated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/05/19
ADAM
04/05/19
NO CHANGE
Target $70
ADAM
Buy
Cubic price target lowered to $70 from $74 at Canaccord
Canaccord analyst Ken Herbert maintained a Buy on Cubic but lowered his price target to $70 from $74, saying that he believes the recent weakness creates an opportunity, as he does not believe the Goal 2020 upside is reflected in the stock. Herbert also says he believes investors are waiting for better clarity on the near-term catalysts, especially considering the uncertainty around returns from recent acquisitions.
05/13/19
RAJA
05/13/19
UPGRADE
RAJA
Strong Buy
Cubic upgraded to Strong Buy from Outperform at Raymond James
05/13/19
05/13/19
UPGRADE
Target $82

Strong Buy
Cubic upgraded to Strong Buy, shares undervalued, says Raymond James
As previously reported, Raymond James upgraded Cubic to Strong Buy from Outperform with a $82 price target. Analyst Brian Gesuale believes investors are underestimating backlog growth and quality and have been focused on choppy quarterly results. The analyst sees an opportunity for investors to take advantage of long-term fundamentals and sees a path to an intrinsic value of $109 over the next two years.
FARO Faro Technologies
$49.70

0.64 (1.30%)

05/03/19
NEED
05/03/19
DOWNGRADE
NEED
Hold
Faro Technologies downgraded to Hold from Buy at Needham
02/21/19
02/21/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Canon (CAJ) upgraded to Neutral from Sell at Goldman Sachs with analyst Satoru Ogawa citing the company's cost cuts and less downside to his price target. 2. Boston Beer (SAM) upgraded to Neutral from Underperform at Macquarie with analyst Caroline Levy saying she forcasts the company's non-beer portfolio that includes Twisted Tea,Truly and Angry Orchard brands to help contribute to its double-digit revenue growth in 2019. 3. U.S. Steel (X) upgraded to Buy from Hold at Berenberg with analyst Paretosh Misra citing an increase in EBITDA estimates from higher pricing. 4. FARO Technologies upgraded to Buy from Hold at Gabelli with analyst Hendi Susanto citing an attractive valuation and positive view on the company's "growth execution and initiatives toward operating margin improvement in 2019." 5. Aaron's (AAN) upgraded to Buy from Neutral at Northcoast with analyst Tim Vierengel saying the Best Buy (BBY) partnership is a key point of growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/21/19
02/21/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Garmin (GRMN) downgraded to Neutral from Buy at Longbow with analyst Nikolay Todorov saying its upside potential is limited by valuation following a 17% rally in the stock price yesterday. 2. Biogen (BIIB) downgraded to Hold from Buy at Stifel with analyst Paul Matteis saying the stock has been "remarkably resilient" in the wake of two recent events - Roche's (RHHBY) crenezumab futility and Tecfidera's inter partes review institution. However, both these events "imply elevated risk to the long-term bull case." 3. Faro Technologies (FARO) downgraded to Hold from Buy at Craig-Hallum with analyst Greg Palm citing increasing risks to the company's near term growth and margin targets. 4. D.R. Horton (DHI) and Lennar (LEN) downgraded to Neutral from Outperform at Wedbush. 5. General Mills (GIS) downgraded to Hold from Buy at Standpoint Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/19
NEED
05/03/19
DOWNGRADE
NEED
Hold
Faro Technologies downgraded to Hold from Buy at Needham
Needham analyst James Ricchiuti downgraded Faro Technologies to Hold after its "weak" Q1 results that showed slowing revenue growth to 5% vs. consensus forecast of 8%. The analyst attributes the slowdown to the "reorganization in the 3D manufacturing segment" that resulted in higher headcount turnover and weaker orders, noting that while the efforts may have longer term benefits, the disruption is likely to persist for the balance of 2019.
FLIR Flir Systems
$47.31

0.04 (0.08%)

05/22/19
05/22/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Flir Systems (FLIR) upgraded to Outperform from In-Line at Imperial Capital with analyst Jeff Kessler saying after attending recent conferences, he believes prospects for Flir's safe cities and other civilian projects will improve starting in 2020. 2. Legg Mason (LM) upgraded to In Line from Underperform at Evercore ISI with analyst Glenn Schorr saying that with Legg Mason having made "a bunch of progress" toward accomplishing the mission of becoming a more stable company and now with the presence of an activist that should help them extract some more expense synergies, it does not feel like an underperform to him anymore. 3. Ericsson (ERIC) upgraded to Buy from Neutral at BofA/Merrill with analyst Tal Liani citing its 5G leadership and potential for longer-term share gains as well as the U.S. pressures on Huawei, which he thinks may add to Ericsson share gains. 4. Redfin (RDFN) upgraded to Neutral from Underperform at DA Davidson with analyst Tom White saying his proprietary data suggest that the company's listing share trends are not only improving but "establishing new highs." 5. AES Corp. (AES) upgraded to Buy from Hold at Argus with analyst Gary Hovis saying the company is now better positioned to generate "more consistent" earnings and dividend growth while trading at a "reasonable" valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/18/19
RAJA
03/18/19
DOWNGRADE
RAJA
Outperform
Flir Systems downgraded to Outperform from Strong Buy at Raymond James
03/18/19
03/18/19
DOWNGRADE

Outperform
Flir Systems downgraded to Outperform from Strong Buy at Raymond James
As previously reported, Raymond James analyst Brian Gesuale downgraded Flir Systems to Outperform from Strong Buy and lowered his price target on shares to $60 from $65. The analyst said that many of the catalysts in his July 2017 upgrade of Flir -- potential divestitures, leadership change, discount valuation, under-levered balance sheet, accelerating sales and margins -- have "largely played out," and he is struggling to see new near-term catalysts to justify a Strong Buy rating. He noted that since July 2017, Flir's stock is up 40%.
05/22/19
IMPC
05/22/19
UPGRADE
Target $57
IMPC
Outperform
Flir Systems upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital analyst Jeff Kessler upgraded Flir Systems to Outperform from In-Line and raised his price target for the shares to $57 from $56. After attending recent conferences, the analyst believes prospects for Flir's safe cities and other civilian projects will improve starting in 2020. Any combination of new government project wins or higher-margin areas of Industrial or Commercial could drive revenue growth close to 5% and operating margins closer to 23%-plus, Kessler tells investors in a research note. He thinks Flir can efficiently manage its business and pay down debt with free cash flows.
IPGP IPG Photonics
$121.87

3.18 (2.68%)

05/01/19
DADA
05/01/19
NO CHANGE
Target $205
DADA
Buy
IPG Photonics price target raised to $205 from $175 at DA Davidson
DA Davidson analyst Thomas Diffely raised his price target on IPG Photonics to $205 and kept his Buy rating, saying the company's latest quarter highlighted its capability to fend off competitive pricing challenges through product cost reduction and technical initiatives. The analyst notes that his bullish thesis on the shares remains intact given the "improving trends in China, stabilizing business in Europe, and further share gains opportunities."
07/17/19
NEED
07/17/19
NO CHANGE
Target $150
NEED
Buy
IPG Photonics price target lowered to $150 from $185 at Needham
Needham analyst James Ricchiuti lowered his price target on IPG Photonics to $150, saying his estimates for the second half of 2019 and for 2020 are being reduced given the "more uncertain" macro environment evidenced by the latest PMI data and slower demand in "key verticals" such as automotive. The analyst notes that his prior estimates overestimated the extent of the company's recovery, adding that pricing pressure from suppliers in China could also cap the gross margin recovery that he was previously modeling. Ricchiuti maintains his Buy rating on IPG Photonics and claims that greater diversification of its product portfolio and a more "balanced geographic distribution" should help.
07/31/19
DADA
07/31/19
NO CHANGE
Target $175
DADA
Buy
IPG Photonics price target lowered to $175 from $205 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on IPG Photonics to $175, saying the industrial laser market recovery that started in Q1 has been reversed by two months of deteriorating market conditions which should keep activity below expectations during the second half of 2019. The analyst keeps his Buy rating on IPG Photonics longer term however given its position as a "technology leader and low cost provider".
IRBT iRobot
$66.19

0.63 (0.96%)

06/10/19
RAJA
06/10/19
NO CHANGE
RAJA
iRobot estimates lowered at Raymond James on tariff increase
Raymond James analyst Brian Gesuale maintained a Market Perform rating on iRobot, but lowered his FY19 and FY20 EPS estimates on the stock due to Trump's latest tariff hike and the "lack of visibility that a resolution will materialize any time soon."
07/03/19
SBSH
07/03/19
NO CHANGE
SBSH
Spending trends favorable for Logitech, unfavorable for GoPro, says Citi
After surveying 75 retail and electronics stores in U.S. throughout June to inquire about promotions and sell-through, Citi analyst Asiya Merchant says spending trends are favorable for both Logitech (LOGI) and Corning (GLW) and unfavorable for GoPro (GPRO). Across categories, TVs stood out as the category most likely to be the top selling consumer electronics product and highest category to exceed sales expectations, while digital cameras are least likely to be a top seller and most likely to miss, Merchant tells investors in a research note. The analyst believes video gaming accessories trends are positive for Logitech while digital camera trends are negative for GoPro. The digital camera market is at historical lows, contends Merchant. The analyst keeps a Buy rating on Logitech shares with a $46 price target. She also lowered her price target for Neutral-rated iRobot (IRBT) to $95 from $100 to reflect the 25% tariff levied on robotic vacuums. Merchant adds that the survey yield "mixed" results for robotic vacuums.
04/25/19
PIPR
04/25/19
NO CHANGE
Target $96
PIPR
Overweight
iRobot needs 'big' second half to meet 2019 guidance, says Piper Jaffray
iRobot reported March quarter results that missed Street revenue expectations but comfortably beat on the bottom line thanks to a tax benefit, Piper Jaffray analyst Troy Jensen tells investors in a research note. Further, the Q1 sales softness was matched with an unexpected ramp in Q2 operating expenditures, which brought the Q2 earnings guidance well below consensus, adds the analyst. With the company reiterating 2019 guidance, this implies a "big" second half is needed to reach the company's goals and full year consensus expectations, says Jensen. The analyst, who has been Neutral on iRobot shares given valuation concerns, maintains his rating and $96 price target even after yesterday's selloff.
07/24/19
PIPR
07/24/19
NO CHANGE
Target $75
PIPR
Neutral
iRobot price target lowered to $75 from $96 at Piper Jaffray
Piper Jaffray analyst Troy Jensen lowered his price target on iRobot shares to $75 from $96 after the company reported mixed Q2 results and lowered its 2019 revenue and earnings expectations, citing the 25% tariffs on Chinese-made products that have been put into effect by the U.S. iRobot has a robust product pipeline that will be a tailwind for revenue growth in 2020, but it will continue to be impacted by tariff costs until a China/U.S. trade settlement or until the company can shift more of its manufacturing, said Jensen, who keeps a Neutral rating on the stock.
KRNT Kornit Digital
$27.88

0.31 (1.12%)

04/04/19
NEED
04/04/19
NO CHANGE
Target $30
NEED
Buy
Kornit Digital price target raised to $30 from $24 at Needham
Needham analyst James Ricchiuti raised his price target on Kornit Digital to $30 after attending the company's customer event at its headquarters where it showcased its "new disruptive Poly Pro print technology and the new mass production Atlas direct-to-garment system." The analyst says Kornit Digital's presentation has raised his optimism about his forecast of 25% revenue growth in 2019 as well as the management's scaling expectations to achieve $500M in revenue by the end of 2023. Ricchiuti claims that Kornit Digital is one of his "more compelling growth stories" and keeps his Buy rating on the shares.
05/07/19
05/07/19
NO CHANGE

Kornit Digital named a strong sell at Spruce Point
06/18/19
NEED
06/18/19
NO CHANGE
Target $34
NEED
Buy
Kornit Digital price target raised to $34 from $32 at Needham
Needham analyst James Ricchiuti raised his price target on Kornit Digital to $34 and kept his Buy rating after the company's $130M equity raise last week. The analyst says the offering brings Kornit Digital's net cash position to about $250M and gives it "considerable flexibility" to pursue strategic acquisitions and to further fund its "strong" organic growth, which he expects to remain the primary catalyst for the company.
07/30/19
WBLR
07/30/19
NO CHANGE
WBLR
Outperform
Amazon's Salt Lake City permit close to final approval, says William Blair
Amazon's (AMZN) application with the Utah Department of Environmental Quality to set up an inkjet printing facility in Salt Lake City is close to final approval, William Blair analyst Brian Drab tells investors in a research note. On July 25, the DEQ sent Amazon a letter indicating intent to approve the proposed project, says the analyst. The public has about one month to comment on the approval and those comments will be considered before final approval is given, he notes. While the application and approval letter do not specify Kornit Digital (KRNT) printers, Drab is "highly confident" the printers to be installed in the facility will be supplied by Kornit. The documents describe the printing process to be employed as the application of ink immediately following the application of a fixation agent, says the analyst. Kornit is the only digital textile printer on the market using this patented process, contends Drab. The analyst now has increased confidence in his forecast for Kornit Digital for the second half of 2019 and he sees the potential for upside to current assumptions regarding revenue from Amazon. He keeps an Outperform rating on Kornit Digital.
LASR nLight
$14.85

0.38 (2.63%)

08/06/19
CHLM
08/06/19
NO CHANGE
Target $16
CHLM
Hold
nLight price target lowered to $16 from $23 at Craig-Hallum
Craig-Hallum analyst Greg Palm lowered his price target for nLight to $16 from $23 after the company reported mixed results. While Q2 was essentially in-line, Q3 guidance and the implied outlook for Q4 was considerably worse, he notes. The analyst reiterates a Hold rating on the shares.
08/06/19
DADA
08/06/19
NO CHANGE
Target $20
DADA
nLight price target lowered to $20 from $28 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on nLight to $20 after its Q2 earnings miss and below-consensus Q3 revenue guidance, saying its quarters echoed the industry concerns around the escalating trade tensions between U.S. and China. The analyst also cites the slowing industrial laser market and the pricing pressure coming from the company's domestic competitors in China, stating that there is now "little visibility into the timing or magnitude of a recovery." Diffely maintains a Buy rating on nLight longer term, adding that the company's Aerospace and Defense segment remains a "bright spot" with its sixth consecutive quarter of double-digit growth.
08/06/19
ADAM
08/06/19
NO CHANGE
Target $18
ADAM
Buy
nLight price target lowered to $18 from $28 at Canaccord
Canaccord analyst Jed Dorsheimer lowered his price target on nLight to $18 from $28 following its inline Q2 results and lowered guidance. The guidance was not shocking given the recent commentary surrounding China that other industry participants have reported. In addition to China weakness, price competition is intense in lower power lasers so investors should focus on the longer-term opportunity for the company. Dorsheimer maintained his Buy rating on nLight shares.
07/17/19
NEED
07/17/19
NO CHANGE
Target $21
NEED
Buy
nLight price target lowered to $21 from $26 at Needham
Needham analyst James Ricchiuti lowered his price target on nLight to $21 to reflect the slowing conditions in the Industrial and Microfabrication areas of its business. The analyst keeps his Buy rating on the stock however and believes that the company can navigate the "choppy macro environment", stating that its microfabrication business is "diverse enough" to insulate it from cyclically weak markets. Ricchiuti adds that nLight's underperformance relative to its peer group is unwarranted.
MKSI MKS Instruments
$75.90

1.93 (2.61%)

04/17/19
DBAB
04/17/19
NO CHANGE
Target $115
DBAB
Buy
MKS Instruments price target raised to $115 from $100 at Deutsche Bank
Deutsche Bank analyst Sidney Ho raised his price target for MKS Instruments to $115 from $100 and keeps a Buy rating on the shares. MKS' semis business remains stable and is not yet at an inflection point, but its diversification strategy remains underappreciated, Ho tells investors in a research note. The analyst believes that with ~50% of its business not directly impacted by the semi cycle and with organic and non-organic growth opportunities in other advanced markets, MKS is set up well to be less volatile than its semicap peers and to potentially outgrow them. He views the stock as "mispriced" at current levels.
05/15/19
SUSQ
05/15/19
INITIATION
SUSQ
Positive
MKS Instruments initiated with a Positive at Susquehanna
Susquehanna analyst David Ryzhik initaited MKS Instruments with a Positive and $123 price target.
05/15/19
05/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Target Hospitality (TH) initiated with a Buy at Stifel. 2. Palomar (PLMR) initiated with an Outperform at William Blair. 3. MKS Instruments (MKSI) initiated with a Positive at Susquehanna. 4. Pinduoduo (PDD) initiated with a Buy at BofA/Merrill. 5. Four Corners Property Trust (FCPT) initiated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/02/19
STFL
04/02/19
NO CHANGE
Target $128
STFL
Buy
MKS Instruments price target raised to $128 from $100 at Stifel
Stifel analyst Patrick Ho updated his 2019 estimates for MKS Instruments and introduced 2020 estimates that incorporate the newly acquired Electro Scientific Industries, leading him to raise his price target on MKS shares to $128 from $100. The analyst, who noted he is projecting strong growth in its non-semis business in 2020, is also more optimistic on a recovery in Wafer Fab Equipment. He sees MKS Instruments being poised to benefit from this recovery and thinks it can outperform peers with its diversified approach, Ho said. He maintains a Buy rating on MKS shares.
PI Impinj
$38.00

1.88 (5.20%)

07/30/19
ADAM
07/30/19
NO CHANGE
Target $39
ADAM
Buy
Impinj price target raised to $39 from $35 at Canaccord
Canaccord analyst T. Michael Walkley raised his price target on Impinj to $39 from $35 following strong Q2 results. The analyst anticipates strong long-term growth trends driven by new industry broader adoption after it cleared hundreds of millions of endpoint inventory. Walkley reiterated his Buy rating on Impinj shares.
07/30/19
ROTH
07/30/19
NO CHANGE
Target $38
ROTH
Buy
Impinj price target raised to $38 from $31 at Roth Capital
Roth Capital analyst Scott Searle raised his price target for Impinj to $38 from $31 after the company reported "strong" Q2 results with a generally in-line guide. The analyst reiterates a Buy rating on the shares.
07/01/19
DOTC
07/01/19
UPGRADE
DOTC
Buy
Impinj upgraded to Buy from Neutral at Dougherty
Dougherty analyst Charles Anderson upgraded Impinj to Buy from Neutral and established a $36 price target.
07/30/19
PIPR
07/30/19
NO CHANGE
Target $40
PIPR
Overweight
Impinj price target raised to $40 from $32 at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for Impinj to $40 from $32 saying the company reported "strong" June quarter results. The analyst believes the RFID market has entered a new phase of growth with broad based strength across multiple verticals. And while Impinj's September quarter guidance was slightly below plan, management has exceeded the high-end of guidance for the past five quarters, Jensen tells investors in a research note. He believes the company is being conservative and reiterates an Overweight rating on the shares.
TTMI TTM Technologies
$10.63

0.09 (0.85%)

08/05/19
JPMS
08/05/19
DOWNGRADE
Target $14
JPMS
Neutral
TTM Technologies downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Paul Coster downgraded TTM Technologies to Neutral from Overweight with a $14 price target citing elevated near-term risks following the company's "decent" Q2 results.
05/07/19
NEED
05/07/19
INITIATION
NEED
Hold
TTM Technologies resumed with a Hold at Needham
Needham analyst James Ricchiuti resumed TTM Technologies with a Hold rating, saying that while the company's acquisition of Anaren last year diversified its revenue into "growth potential" markets like Aerospace & Defense and 5G, its 2019 prospects remain constrained by the headwinds in cellular in automotive verticals. The analyst contends that the downside for TTM Technologies is likely to be "limited" however, with long term benefits derived from higher defense spending and 5G buildout.
08/05/19
JPMS
08/05/19
DOWNGRADE
Target $14
JPMS
Neutral
JPMorgan downgrades TTM Technologies to elevated near-term risks
JPMorgan analyst Paul Coster downgraded TTM Technologies (TTMI) to Neutral from Overweight with an unchanged $14 price target. While the shares traded on the "solid" Q2 report, the overall narrative seemed cautious, particularly relating to the company's auto, industrial, and IT hardware segments, Coster tells investors in a research note. TTM's "deep" integration into the Chinese supply-chain and its exposure to Huawei came back into focus following NetApp's (NTAP) negative preannouncement, which suggests enterprise data center investments may slow into Q3, says the analyst. Coster sees a lack of near-term share catalysts and "somewhat elevated risks" for TTM Technologies.
06/18/19
JPMS
06/18/19
NO CHANGE
Target $14
JPMS
Overweight
TTM Technologies estimates lowered on Huawei, Apple exposure at JPMorgan
JPMorgan analyst Paul Coster lowered his 2019 and 2020 estimates for TTM Technologies to reflect the company's direct exposure to Huawei, Apple and the global auto industry, as well as the indirect exposure to tariffs on Chinese-assembled goods for export to the United States. The analyst, however, expects a margin expansion turnaround in the second half of fiscal 2019 and rebound in fiscal 2020 to a more normalized level. He lowered his price target for TTM Technologies to $14 from $15 and maintains an Overweight rating on the name.
EPAY Bottomline Technologies
$42.68

1.07 (2.57%)

08/09/19
CHLM
08/09/19
UPGRADE
CHLM
Buy
Bottomline Technologies upgraded to Buy from Hold at Craig-Hallum
08/09/19
CHLM
08/09/19
UPGRADE
Target $52
CHLM
Buy
Bottomline Technologies upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst George Sutton upgraded Bottomline Technologies to Buy from Hold and raised his price target to $52 from $49 following the company's Q4 earnings report. In a research note to investors, Sutton points out the fact that Bottomline's 28% growth in TTM Subscription & Transaction bookings should nicely support a reacceleration of revenue, adding that the $18.4M of backlog in the Digital Banking segment should be implemented in the back half of FY20.
08/09/19
BRRR
08/09/19
NO CHANGE
BRRR
Outperform
Bottomline Technologies 'remains undervalued', says Barrington
Barrington analyst Gary Prestopino kept his Outperform rating on Bottomline Technologies with a price target in the $60-$65 target range after its Q4 results, saying the below-consensus Q1 guidance was negatively impacted by FX. The analyst notes that the quarter still saw "strong success" in bookings and continued product innovation, helping the company grow its subscription and transaction revenues by 15%-20%. Prestopino further states that the stock remains undervalued, which is underscored by its recently announced $50M stock buyback.
05/24/19
SPHN
05/24/19
NO CHANGE
SPHN
Global Payments, TSYS tie-up would likely be highly accretive, says Stephens
Stephens analyst Brett Huff noted that Bloomberg reports that Global Payments (GPN) and TSYS (TSS) have held talks about a potential merger, joint venture and/or partnerships. While he has previously thought that Global Payments had the luxury of "waiting and seeing" if combining consumer funding account with a merchant POS experience, such as the Fiserv (FISV)-First Data (FDC) and FIS (FIS)-Worldpay (WP) deals will do, would yield enough strategic value, he suspects a sooner deal might be driven by the companies' desire to not just achieve larger scale but also achieve that scale with high-quality assets. Huff said he thinks any deal would likely be highly accretive given overlaps and both companies' track record for realizing cost synergies and he also sees limited antitrust concern. Huff also thinks a Global Payments-TSYS combination would increase the chances that assets such as ACI Worldwide (ACIW), Bottomline Technologies (EPAY), Jack Henry (JKHY), USA Technologies (USAT) and Q2 Holdings (QTWO) would likely be bought.
EVER EverQuote
$21.28

1.4 (7.04%)

08/06/19
OPCO
08/06/19
NO CHANGE
Target $19
OPCO
Outperform
EverQuote price target raised to $19 from $13 at Oppenheimer
Oppenheimer analyst Jed Kelly raised his price target for EverQuote to $19 from $13 based on improving marketing efficacy and higher conversion expanding share of insurance carriers' marketing budgets. The analyst believes EverQuote is growing over 2-times online insurance advertising, and is incrementally encouraged on its second half of the year outlook where management is increasing its 2019 forecast on accelerating revenue from higher consumer volumes, strong industry tailwinds, and stable auction dynamics where nine of its top ten carriers increased spending. Kelly reiterates an Outperform rating on the shares.
08/06/19
08/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Northrop Grumman (NOC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Rajeev Lalwani citing his view that an opportunity for continued outperformance exists in Defense stocks. 2. Bancolombia (CIB) upgraded to Overweight from Neutral at JPMorgan and to Neutral from Underperform at Credit Suisse. 3. Ford (F) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying Ford's partnerships and "more focused" model lineup should keep its profitability "largely stable" through 2022. 4. Aimco (AIV) upgraded to Buy from Neutral at Mizuho with analyst Haendel St. Juste saying the company trades at a "two-turn multiple discount" to peers based on estimates 2020 funds from operations as well as a 10% discount to consensus net asset value versus peers' 2% premium. 5. EverQuote (EVER) upgraded to Outperform from Market Perform at Raymond James with analyst Aaron Kessler citing the company's "strong" Q2 results and outlook. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/19
NEED
08/06/19
NO CHANGE
Target $20
NEED
Buy
EverQuote price target raised to $20 from $13 at Needham
Needham analyst Mayank Tandon raised his price target on EverQuote to $20 and kept his Buy rating after its Q2 earnings beat and raised FY19 outlook, along with the management's expectations of positive EBITDA to come in FY19 and in the subsequent years. The analyst is positive on the stock as a "leading consumer insurance marketplace", citing the company's improving volume trends, continued development of additional insurance verticals, and the benefits of secular tailwinds coming from an online shift in insurance advertising spending.
08/06/19
RAJA
08/06/19
UPGRADE
Target $20
RAJA
Outperform
EverQuote upgraded to Outperform on 'strong' results, says Raymond James
Raymond James analyst Aaron Kessler upgraded EverQuote to Outperform from Market Perform with a $20 price target citing the company's "strong" Q2 results and outlook. In a research note to investors, Kessler says he expects revenue growth to continue to accelerate into 2020 driven by stronger growth in quote requests, and estimates the company's VMM will be 29.5% in 2019 and high-30's long-term. While still early, Kessler says he remains optimistic on new verticals, including recently launched health insurance.
WNS WNS Holdings
$62.70

0.36 (0.58%)

07/19/19
CANT
07/19/19
NO CHANGE
Target $68
CANT
Overweight
WNS Holdings price target raised to $68 from $63 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi raised his price target for WNS Holdings to $68 from $63 saying demand remains robust following the company's fiscal Q1 results. WNS has not had any impact on the business from macro headwinds, and management believes the environment could translate into healthy demand for strategic BPM initiatives, Foresi tells investors in a research note. The analyst sees room for multiple expansion and keeps an Overweight rating on WNS Holdings.
04/26/19
BRRR
04/26/19
NO CHANGE
Target $68
BRRR
Outperform
WNS Holdings price target raised to $68 from $60 at Barrington
Barrington analyst Vincent Colicchio raised his price target for WNS Holdings to $68 from $60 following the company's better than expected fiscal Q4 results. While the company added 25 new clients in fiscal 2019 versus 29 in fiscal 2018, the average annual contract value of the deals added in fiscal 2019 increased 35% year-over-year, Colicchio tells investors in a post-earnings research note. He believes this should help WNS generate "strong" revenue growth over the next few years. The analyst keeps an Outperform rating on the shares.
07/19/19
BRRR
07/19/19
NO CHANGE
Target $72
BRRR
Outperform
WNS Holdings price target raised to $72 from $68 at Barrington
Barrington analyst Vincent Colicchio raised his price target for WNS Holdings to $72 from $68 saying broad demand drove "solid" growth the company's fiscal Q1 results. WNS's sales pipeline grew "rapidly" year-over-year, was broad based across multiple geographies, verticals and service lines and included several large transformation deals, Colicchio tells investors in a post-earnings research note. He reiterates an Outperform rating on the shares.
07/19/19
COWN
07/19/19
NO CHANGE
Target $70
COWN
Outperform
WNS Holdings price target raised to $70 from $62 at Cowen
Cowen analyst Bryan Bergin raised his price target on WNS Holdings to $70 from $62 following Q1 results. The analyst said the company continues to impress with consistent execution driving solid growth and margin outperformance. He said he still sees upside factors to support estimates and multiple expansion. The core business remains healthy while growing new engagement types and client categories. Bergin reiterated his Outperform rating on WNS Holdings shares.

TODAY'S FREE FLY STORIES

ABT

Abbott

$84.25

-0.96 (-1.13%)

, ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

13:22
09/14/19
09/14
13:22
09/14/19
13:22
Conference/Events
William Blair diagnostic products/med tech analyst to hold a group luncheon »

Diagnostic Products &…

ABT

Abbott

$84.25

-0.96 (-1.13%)

ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

BDX

Becton Dickinson

$260.68

-1.41 (-0.54%)

COO

Cooper Companies

$301.95

-3 (-0.98%)

EXAS

Exact Sciences

$106.72

-1.99 (-1.83%)

GH

Guardant Health

$77.54

0.49 (0.64%)

NEO

NeoGenomics

$21.34

-1.22 (-5.41%)

LMNX

Luminex

$22.62

0.1 (0.44%)

HAE

Haemonetics

$125.55

-0.31 (-0.25%)

STAA

STAAR Surgical

$29.21

0.415 (1.44%)

QGEN

Qiagen

$33.97

-0.105 (-0.31%)

NVTA

Invitae

$21.70

-0.2 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 13

    Nov

  • 05

    Dec

CRTO

Criteo

, TWTR

Twitter

13:19
09/14/19
09/14
13:19
09/14/19
13:19
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

Technology & Internet…

CRTO

Criteo

TWTR

Twitter

SNAP

Snap

GOOGL

Alphabet Class A

FB

Facebook

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

T

AT&T

$37.90

-0.46 (-1.20%)

09:06
09/14/19
09/14
09:06
09/14/19
09:06
Periodicals
AT&T stock already benefiting from activist involvement, Barron's says »

AT&T 's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

DIS

Disney

$138.00

0.44 (0.32%)

, NFLX

Netflix

$294.00

5.08 (1.76%)

09:04
09/14/19
09/14
09:04
09/14/19
09:04
Periodicals
Consumers might not be as in love with Apple TV+ as Wall Street, Barron's says »

Following Apple's…

DIS

Disney

$138.00

0.44 (0.32%)

NFLX

Netflix

$294.00

5.08 (1.76%)

AAPL

Apple

$218.71

-4.4 (-1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Oct

UAL

United Airlines

$91.37

1.99 (2.23%)

08:58
09/14/19
09/14
08:58
09/14/19
08:58
Periodicals
United Airlines could get boost after short squeeze, Barron's says »

United Airlines stock has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

BAC

Bank of America

$30.12

0.44 (1.48%)

08:55
09/14/19
09/14
08:55
09/14/19
08:55
Periodicals
Bank of America stock worth betting on, Barron's says »

Amid talk of a coming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

TPR

Tapestry

$25.16

-0.43 (-1.68%)

08:49
09/14/19
09/14
08:49
09/14/19
08:49
Periodicals
Coach parent's turnaround could be coming, Barron's says »

Even in a rough year for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHAL

Amerco

$379.63

4.21 (1.12%)

08:45
09/14/19
09/14
08:45
09/14/19
08:45
Periodicals
U-Haul parent stock 'a better-kept secret,' Barron's says »

Amerco (UHAL), owner of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$228.59

-1.38 (-0.60%)

, CNI

Canadian National

$92.13

-0.31 (-0.34%)

08:41
09/14/19
09/14
08:41
09/14/19
08:41
Periodicals
Railroad stocks struggling as challenges increase, Barron's says »

North American railroads…

CP

Canadian Pacific

$228.59

-1.38 (-0.60%)

CNI

Canadian National

$92.13

-0.31 (-0.34%)

UNP

Union Pacific

$171.49

3.81 (2.27%)

CSX

CSX

$72.50

0.96 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

MO

Altria Group

$42.01

-0.77 (-1.80%)

, BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

08:06
09/14/19
09/14
08:06
09/14/19
08:06
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

MO

Altria Group

$42.01

-0.77 (-1.80%)

BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$73.01

-1.89 (-2.52%)

REGI

Renewable Energy

$15.90

0.57 (3.72%)

PSX

Phillips 66

$102.77

0.66 (0.65%)

MPC

Marathon Petroleum

$53.29

0.1 (0.19%)

VLO

Valero

$85.53

1.84 (2.20%)

EVA

Enviva

$31.21

0.06 (0.19%)

AMTX

Aemetis

$1.00

0.14 (16.28%)

PEIX

Pacific Ethanol

$0.78

0.0322 (4.29%)

GPP

Green Plains Partners

$13.18

0.17 (1.31%)

DK

Delek US

$35.91

-0.6 (-1.64%)

HFC

HollyFrontier

$51.41

0.71 (1.40%)

TSO

Tesoro

$0.00

(0.00%)

WNR

Western Refining

$0.00

(0.00%)

T

AT&T

$37.90

-0.46 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 23

    Oct

  • 24

    Oct

  • 31

    Oct

  • 12

    Nov

GLD

SPDR Gold Shares

$140.19

-1.14 (-0.81%)

17:58
09/13/19
09/13
17:58
09/13/19
17:58
Hot Stocks
SPDR Gold Shares holdings fall to 874.51MT from 880.37MT »

This is the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$10.22

0.595 (6.18%)

, AIMT

Aimmune

$24.66

(0.00%)

17:57
09/13/19
09/13
17:57
09/13/19
17:57
Hot Stocks
Breaking Hot Stocks news story on DBV Technologies, Aimmune »

DBV Technologies falls 2%…

DBVT

DBV Technologies

$10.22

0.595 (6.18%)

AIMT

Aimmune

$24.66

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

AIMT

Aimmune

$24.66

(0.00%)

17:55
09/13/19
09/13
17:55
09/13/19
17:55
Hot Stocks
FDA committee votes to support use of Aimmune's Palforzia for peanut allergy »

Aimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

ZAYO

Zayo Group

$33.82

-0.05 (-0.15%)

17:39
09/13/19
09/13
17:39
09/13/19
17:39
Hot Stocks
Zayo Group CEO sells 1M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

T

AT&T

$37.90

-0.46 (-1.20%)

, MO

Altria Group

$42.01

-0.77 (-1.80%)

17:38
09/13/19
09/13
17:38
09/13/19
17:38
Periodicals
CNN to longer run Juul ads, Daily Beast reports »

AT&T's (T) CNN…

T

AT&T

$37.90

-0.46 (-1.20%)

MO

Altria Group

$42.01

-0.77 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BAS

Basic Energy

$1.87

-0.08 (-4.10%)

17:34
09/13/19
09/13
17:34
09/13/19
17:34
Hot Stocks
Basic Energy CEO T.M. Patterson to leave company »

Basic Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

XBIO

Xenetic

$1.61

-0.04 (-2.42%)

17:28
09/13/19
09/13
17:28
09/13/19
17:28
Syndicate
Breaking Syndicate news story on Xenetic »

Xenetic files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$218.71

-4.4 (-1.97%)

, DIS

Disney

$138.00

0.44 (0.32%)

17:22
09/13/19
09/13
17:22
09/13/19
17:22
Hot Stocks
Disney CEO Bob Iger resigns from Apple board of directors »

In a regulatory filing,…

AAPL

Apple

$218.71

-4.4 (-1.97%)

DIS

Disney

$138.00

0.44 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PHG

Philips

$47.79

0.19 (0.40%)

17:21
09/13/19
09/13
17:21
09/13/19
17:21
Hot Stocks
Philips awarded maximum $400M Defense Logistics Agency contract »

Philips has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBSE

NeuBase Therapeutics

$5.70

-0.04 (-0.70%)

17:20
09/13/19
09/13
17:20
09/13/19
17:20
Syndicate
Breaking Syndicate news story on NeuBase Therapeutics »

NeuBase Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

KDMN

Kadmon

$2.80

-0.015 (-0.53%)

17:18
09/13/19
09/13
17:18
09/13/19
17:18
Syndicate
Breaking Syndicate news story on Kadmon »

Kadmon files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.80

-0.015 (-0.53%)

17:18
09/13/19
09/13
17:18
09/13/19
17:18
Syndicate
Breaking Syndicate news story on Kadmon »

Kadmon files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$198.82

1.22 (0.62%)

17:17
09/13/19
09/13
17:17
09/13/19
17:17
Hot Stocks
Raytheon awarded $427.3M Army procurement contract »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

INPX

Inpixon

$0.14

-0.0001 (-0.07%)

17:16
09/13/19
09/13
17:16
09/13/19
17:16
Syndicate
Breaking Syndicate news story on Inpixon »

Inpixon files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$6.59

0.14 (2.17%)

17:14
09/13/19
09/13
17:14
09/13/19
17:14
Syndicate
Aurinia Pharmaceuticals files to sell $40M of common shares at-the-market »

Aurinia Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.